Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

5.68
Delayed Data
As of Jun 30
 +0.045 / +0.80%
Today’s Change
3.71
Today|||52-Week Range
10.44
+24.45%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization1.1K2.0K1.0K2.0K
 
 
 
 
 
 
Operating ExpensesGross Income-1.1K-2.0K-1.0K-2.0K
 
 
 
 
 
General Expenses1.9M1.7M1.9M1.7M
 
 
 
 
 
Research And Development1.1M858.0K1.3M1.1M
 
 
 
 
 
Total Operating Expenses1.9M1.7M1.9M1.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.9M-1.7M-1.9M-1.7M
 
 
 
 
 
Other Expenses31.5K93.0K-5.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.8M-1.6M-1.9M-1.6M
 
 
 
 
 
Income Taxes0.00-4.0K0.000.00
 
 
Net Income-1.8M-1.6M-1.9M-1.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.9M10.1M10.1M10.8M
 
 
 
 
 
Shares To Calculate EPS Diluted9.9M10.1M10.1M10.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.18---$0.19-$0.15
 
 
 
 
EPS Diluted-$0.18-$0.16-$0.19-$0.15
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account